M&A Deal Summary |
|
|---|---|
| Date | 2022-12-21 |
| Target | IsoPlexis |
| Sector | Life Science |
| Buyer(s) | Bruker Cellular Analysis |
| Deal Type | Add-on Acquisition |
| Deal Value | 58M USD |
| Advisor(s) | Evercore Group (Financial) Cravath, Swaine & Moore (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2011 |
| Sector | Life Science |
| Revenue | 79M USD (2022) |
Bruker Cellular Analysis is a functional cell biology company that provides single-cell biology research tools to deliver deep insights into cellular function and new perspectives on phenomes and genotype-to-phenotype linkages. It enables scientists to reveal the most complete insights into cell function and obtain a full view of the behavior of each cell. Bruker Cellular Analysis was incorporated in 2011 and is based in EmeryVille, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
